Increased platelet aggregation in early diabetus mellitus.
In view of the tendency toward vascular disease in diabetes mellitus, we studied platelet aggregation in 15 normal, 7 prediabetic, 12 latent, and 20 frankly diabetic subjects. Platelets from latent and frank diabetics showed increased platelet aggregation 4 minutes after adding adenosine 5'-diphosphate (60% verus 29% at 1.0 mu-M), epinephrine (46% versus 14% at 0.25 mu-M), and collagen (72% versus 17% at 0.25 mu-g/ml). Three prediabetics had increased platelet aggregation. Platelet sensitivity to aggregating agents was most marked in frank diabetics, intermediate in latent diabetics, and least in prediabetics. Second-phase platelet aggregation was reversed with acetylsalicylic acid, intravenous tolbutamide, and oral glucose administration. We conclude that platelet aggregation may be increased early in diabetes mellitus and may be involved in the genesis of diabetic microangiopathy. Prospective studies on the effect of therapeutic agents such as acetylsalicylic acid on the natural course of diabetic vascular disease are indicated.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000284:Administration, Oral; D001241:Aspirin / Q000494:pharmacology; D003094:Collagen / Q000494:pharmacology; D003920:Diabetes Mellitus / Q000097:blood*; D003925:Diabetic Angiopathies / Q000209:etiology; D004837:Epinephrine / Q000494:pharmacology; D005947:Glucose / Q000008:administration & dosage / Q000494:pharmacology; D005951:Glucose Tolerance Test; D006801:Humans; D066298:In Vitro Techniques; D010973:Platelet Adhesiveness; D010974:Platelet Aggregation / Q000187:drug effects; D011236:Prediabetic State / Q000097:blood; D013997:Time Factors; D014044:Tolbutamide / Q000494:pharmacology
D000244:Adenosine Diphosphate; D003094:Collagen; D014044:Tolbutamide; D005947:Glucose; D001241:Aspirin; D004837:Epinephrine